Close Menu

NEW YORK (360Dx) – Quest Diagnostics today reported 3 percent year-over-year growth in revenues for the second quarter, but fell short of analysts' average estimate.

Revenue was $1.92 billion for the three-month period ended June 30, up from $1.86 billion in the second quarter 2017. The consensus Wall Street revenue estimate for the quarter was $1.95 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.